This session will explore how cross-border venture capital partnerships can accelerate biotech innovation, commercialization, and global market expansion. Through real portfolio case studies and investment experiences from Europe and Canada, panelists will discuss how international VC networks can provide strategic value beyond capital — including business development, clinical partnerships, operational guidance, talent networks, and access to global healthcare ecosystems.

The discussion will also highlight how cross-border investors can leverage Boston’s globally recognized research and innovation ecosystem — including Harvard University, MIT, Mass General Brigham, Dana-Farber Cancer Institute, and the Broad Institute — to support biotech startup growth and translational innovation. Panelists will share insights on how international collaboration and venture partnerships can help bridge scientific discovery with commercialization opportunities in the global biotech market

• Moderator: Debra Peattie | SV Investment, US
• Olivier Belenger | Seido Capital – Venture capital leader with 30+ years of investment experience.
• Ser-Chen Fu, MD | Pacific 8 Ventures – Healthcare and biotech investor specializing in US–Asia cross-border innovation.